SCHEMBL8765117

SCHEMBL8765117

COc1ccc(-c2cnn(-c3ccccc3)c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
HTT P42858 2/20 0.64
NPSR1 Q6W5P4 2/20 0.64
LMNA P02545 1/20 0.64
HIF1A Q16665 1/20 0.59
GAA P10253 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPT P10636 3/20 0.53
HPGDS O60760 1/20 0.53
MCHR1 Q99705 1/20 0.53
RAB9A P51151 6/20 0.50
NPC1 O15118 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPBWR1 P48145 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KDR P35968 1/20 0.50
MAPKAPK2 P49137 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31276383 0.85 ALDH1A1 (0.61) ALDH1A1HTTNPSR1LMNAHIF1A
SCHEMBL7912407 0.85 NPC1 (0.65) ALDH1A1HTTLMNAHIF1AGAA
SCHEMBL8765024 0.81 RAB9A (0.69) ALDH1A1HTTNPSR1LMNAHIF1A
SCHEMBL31276556 0.79 LMNA (0.58) ALDH1A1NPSR1LMNAHIF1AGAA
SCHEMBL23398941 0.79 HTT (0.54) ALDH1A1HTTNPSR1LMNAHIF1A
SCHEMBL31276354 0.79 NPBWR1 (0.56) ALDH1A1HTTNPSR1LMNAHIF1A
SCHEMBL12854139 0.76 HIF1A (0.69) ALDH1A1HTTLMNAHIF1ARAB9A
SCHEMBL3495891 0.76 KEAP1 (0.61) ALDH1A1HTTNPSR1LMNAHIF1A
SCHEMBL8764353 0.76 NPC1 (0.62) ALDH1A1HIF1AMAPTMCHR1RAB9A
SCHEMBL5431907 0.74 ALDH1A1 (0.49) ALDH1A1HTTNPSR1LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed